• Trials and Research

  Study Sheds Light on MS Therapy Tecfidera’s Mechanism of Action

  Posted by MS News Today Moderator on November 7, 2018 at 6:33 pm

  Multiple sclerosis (MS) treatment Tecfidera (dimethyl fumarate) binds to a specific amino acid in key enzymes to inhibit their activity, a study finds. Click here to find out more about this study and its findings.

  What are your thoughts on this news?

  replied 7 years, 4 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply